Cargando…
Rimonabant Kills Colon Cancer Stem Cells without Inducing Toxicity in Normal Colon Organoids
Colorectal cancer (CRC), like other tumor types, is a highly heterogeneous disease. Within the tumor bulk, intra-tumoral heterogeneity is also ascribable to Cancer Stem Cells (CSCs) subpopulation, characterized by high chemoresistance and the unique ability to retain tumorigenic potential, thus asso...
Autores principales: | Fiore, Donatella, Ramesh, Prashanthi, Proto, Maria C., Piscopo, Chiara, Franceschelli, Silvia, Anzelmo, Serena, Medema, Jan P., Bifulco, Maurizio, Gazzerro, Patrizia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5758598/ https://www.ncbi.nlm.nih.gov/pubmed/29354056 http://dx.doi.org/10.3389/fphar.2017.00949 |
Ejemplares similares
-
Inhibition of Wnt/β-Catenin pathway and Histone acetyltransferase activity by Rimonabant: a therapeutic target for colon cancer
por: Proto, Maria Chiara, et al.
Publicado: (2017) -
Rimonabant and Cannabidiol Rewrite the Interactions between Breast Cancer Cells and Tumor Microenvironment
por: Proto, Maria Chiara, et al.
Publicado: (2023) -
Commentary: Use of Cannabinoids to Treat Acute Respiratory Distress Syndrome and Cytokine Storm Associated With Coronavirus Disease-2019
por: Bifulco, Maurizio, et al.
Publicado: (2021) -
In Vitro Evidence of Statins’ Protective Role against COVID-19 Hallmarks Comptes Rendus
por: Fiore, Donatella, et al.
Publicado: (2022) -
Modified Adenosines Sensitize Glioblastoma Cells to Temozolomide by Affecting DNA Methyltransferases
por: Proto, Maria Chiara, et al.
Publicado: (2022)